Table 1.
Characteristics | FUNDC1 | P value | |
---|---|---|---|
Low expression, N (%) | High expression, N (%) | ||
Age, years | 0.39 | ||
<48 | 13 (15.9) | 20 (24.4) | |
≥48 | 24 (29.3) | 25 (30.5) | |
FIGO stage | 0.56 | ||
IA2 | 1 (1.2) | 1 (1.2) | |
IB1 | 12 (14.6) | 9 (11.0) | |
IB2 | 1 (1.2) | 5 (6.1) | |
IIA | 19 (22.4) | 22 (26.8) | |
IIB | 4 (4.7) | 8 (9.8) | |
Tumor size, cm | 0.13 | ||
<4 | 34 (41.5) | 36 (43.9) | |
≥4 | 3 (3.7) | 9 (10.8) | |
Histology | 0.54 | ||
SCC | 34 (41.5) | 41 (50.0) | |
AC | 2 (2.4) | 1 (1.2) | |
ASC | 1 (1.2) | 3 (3.7) | |
Histological differentiation | 0.73 | ||
Well | 2 (2.4) | 1 (1.2) | |
Moderate | 28 (34.1) | 36 (43.9) | |
Poor | 7 (8.5) | 8 (9.8) | |
Deep stromal invasion | 0.73 | ||
No | 4 (4.9) | 6 (7.3) | |
Yes | 33 (40.2) | 39 (47.6) | |
Lymphovascular space involvement | 0.98 | ||
No | 32 (39.0) | 39 (47.6) | |
Yes | 5 (6.1) | 6 (7.3) | |
Positive parametrium | 0.37 | ||
No | 33 (40.2) | 37 (45.1) | |
Yes | 4 (4.9) | 8 (9.8) | |
Positive surgical margin | 0.45 | ||
No | 35 (42.7) | 44 (53.7) | |
Yes | 2 (2.4) | 1 (1.2) | |
LNM | 0.39 | ||
No | 25 (30.5) | 25 (30.5) | |
Yes | 6 (7.3) | 13 (15.9) | |
Chemotherapy | 0.68 | ||
No | 1 (1.2) | 2 (2.4) | |
Yes | 36 (43.9) | 43 (52.4) | |
Radiotherapy | 1 | ||
No | 0 (0.0) | 0 (0.0) | |
Yes | 37 (45.1) | 45 (54.9) |
SCC, squamous cell carcinoma; AC, adenocarcinoma; ASC, adenosquamous carcinoma; LNM, lymph node metastasis.